This time, it's personal: Enhancing patient response to cancer immunotherapy retrieved 15 May 2024 from https://medicalxpress.com/news/2024-05-personal-patient-response-cancer-immunotherapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Mar 28, 2024Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New insights could unlock immunotherapy for rare, deadly eye cancerNew research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient's T cells outside the body before reinfusing them, can successfully treat this rare and aggressive cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »
Using machine learning to identify patients with cancer that would benefit from immunotherapyA new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.
Source: medical_xpress - 🏆 101. / 51 Read more »
New trial shows immunotherapy post-surgery improves overall survival for kidney cancerFor the first time in fifty years, results from a Phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »
Trial for immunotherapy drug shows promise for aggressive breast cancerUniversity of Hawaiʻi Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms of breast cancer. The trial was led by Naoto T.
Source: medical_xpress - 🏆 101. / 51 Read more »
Engineered peptides open new avenue for immunotherapy drug developmentIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body.
Source: medical_xpress - 🏆 101. / 51 Read more »
Engineered peptides show promise in cancer immunotherapyIn a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body.
Source: NewsMedical - 🏆 19. / 71 Read more »